Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Operations (TTM): -49.63M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -49.63M |
| June 30, 2023 | -45.83M |
| March 31, 2023 | -43.89M |
| December 31, 2022 | -32.94M |
| Date | Value |
|---|---|
| September 30, 2022 | -32.92M |
| June 30, 2022 | -31.02M |
| March 31, 2022 | -29.68M |
| December 31, 2021 | -27.19M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-49.63M
Minimum
Sep 2023
-27.19M
Maximum
Dec 2021
-36.64M
Average
-32.93M
Median
Cash from Operations (TTM) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -385.82M |
| NovaBay Pharmaceuticals Inc | -4.516M |
| Palatin Technologies Inc | -33.74M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -18.27M |